BFR Therapy for Post-Op Rehab of ACL Reconstruction With Quadriceps Tendon Autograft
Launched by BROOKE ARMY MEDICAL CENTER · Aug 19, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new rehabilitation approach for patients recovering from surgery to reconstruct the anterior cruciate ligament (ACL) in the knee. Specifically, the trial is looking at whether adding a technique called Blood Flow Restriction (BFR) therapy to standard rehabilitation can help improve recovery outcomes for patients who have had surgery using a quadriceps tendon graft. Participants will be randomly assigned to either a regular rehab program or one that includes BFR therapy. Throughout the study, researchers will use MRI scans and patient surveys to track progress and improvement over time.
To be eligible for this trial, participants must be active duty military members or beneficiaries of the Department of Defense's healthcare system, aged between 15 and 45, and scheduled for ACL reconstruction surgery. Certain conditions, such as undergoing additional knee surgeries or having specific health issues, may prevent someone from participating. Those who join the trial can expect to undergo imaging tests and complete surveys at various points during their recovery to help researchers gather important data about how well the treatments work.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Active duty member or Department of Defense Military Health System beneficiary
- • 15 to 45 years of age
- • Indicated for ACL reconstruction with quadriceps tendon autograft with evidence of skeletal maturity; no open physes/growth plates
- Exclusion Criteria:
- • Patients undergoing a concomitant surgical procedure that would otherwise require a period of immobilization and/or restricted weight bearing (i.e. meniscal repair, meniscal allograft transplantation, osteochondral allograft transplantation, high tibial osteotomy) will be excluded.
- • Undergoing combined multiligamentous knee injury reconstruction
- • Unable to consistently participate in the prescribed post-operative rehabilitation regimen
- • No patients with a history of recent lower extremity deep vein thrombosis, within the 12 months or on active treatment with anticoagulants, a history of ipsilateral lower extremity lymph node dissection or a history of endothelial dysfunction.
- • Patients that are unable to obtain MRI secondary to either intolerance and/or implanted medical devices that preclude the safe completion of the MRI.
About Brooke Army Medical Center
Brooke Army Medical Center (BAMC) is a premier military medical facility located in San Antonio, Texas, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a leading sponsor of clinical trials, BAMC leverages its expertise in trauma care, surgical interventions, and military medicine to evaluate new treatments and therapies aimed at improving patient outcomes. The center's multidisciplinary team of healthcare professionals and researchers collaborates to uphold the highest standards of ethical conduct and scientific integrity, ensuring that all trials contribute valuable insights to the medical community and enhance the quality of care for service members and their families.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Antonio, Texas, United States
Patients applied
Trial Officials
Andrew J Sheean, MD
Principal Investigator
Brooke Army Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials